Series A Therapeutics Companies

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

Bone Health Technologies is developing a new standard of care for treating osteopenia, the precursor to osteoporosis.

Axoft is a revolutionary seamless interface between brain and machine.

Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.

R1 Therapeutics is a clinical-stage biopharmaceutical company that develops first-in-class treatments for kidney disease patients.

Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.

Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.

Ollin Biosciences operates as a clinical-stage biopharmaceutical company.

ResBiotic develops probiotic and pharmabiotic therapies to alleviate neutrophilic inflammation associated with dysbiosis.

Leal Therapeutics develops novel therapeutics for patients.

CorriXR Therapeutics is a biotechnology company.

One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.

Actithera is a molecular radiotherapeutic company that develops radioligand therapies.

Syntis Bio operates as a late-stage preclinical company that develops oral therapies for obesity, diabetes, and rare diseases.

The #1 super health app in the world. Free, gamified, medically proven.

Parallel Bio develops tools that help in the discovery and development of immunotherapies.

Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.

PhaseV provides AI-driven solutions for efficient clinical development and operations.

Avammune Therapeutics is a drug discovery company.

Spark Biomedical, Inc. is a medical device company developing non-invasive neurostimulation solutions for opioid withdrawal and addiction.

Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.

Tribune Therapeutics specializes in building promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.